Reviews/Dietary Fibre/Fibre aids satiety and weight loss
Systemic · FIBRE-SYS-02 · v2
Across several human trials, soluble and gel-forming fibres made people feel fuller or eat less at the next meal, and higher fibre intake was linked to modest weight loss of roughly one to four kilograms. In the largest analysis of calorie-restricted dieters, fibre intake was the single strongest predictor of how much weight people lost [14]. The effect is not uniform: one fibre type lowered food intake by nearly a quarter while others did nothing [13], and oat beta-glucan had no effect on appetite or intake at all [17]. Some of the weight-loss evidence only appeared in people with particular gut-bacteria profiles [3][5], and gut-hormone changes did not always translate into feeling less hungry [6]. The claim's cautious wording — 'promotes' and 'modest' — fits this mixed but directionally consistent picture, which is why the panel supported it while stopping short of calling it settled.
Direct human randomised trials show soluble and gel-forming or fermentable fibres increase satiety or cut energy intake: Fibersol-2 at 10 g delayed hunger and raised satiety [8], alpha-galacto-oligosaccharides dose-dependently reduced appetite and intake [10], 5 g/100 g alginate lowered ad libitum energy intake by 22% [13], NUTRIOSE raised short-term satiety dose-dependently [16], yellow pea fibre cut buffet intake by 16% [18], and an alginate preload reduced satiety or intake [20]. For weight, resistant starch produced a mean -2.8 kg [4], a natural fibre complex -3.8 kg versus placebo [9], yellow pea fibre -0.87 kg [18], and in POUNDS Lost fibre was the most influential predictor of loss independent of calories [14]. The effect is fibre-type specific, with oat beta-glucan showing no appetite or intake effect at any viscosity [17]. The contested point: The division is whether 'higher fibre intake' behaves as one construct or as a set of fibre-specific effects: gel-forming alginate acted while cellulose, guar and lower doses did not [13], and oat beta-glucan did nothing [17]. A second fault line is mechanistic, since gut-hormone changes did not reliably produce altered subjective appetite or intake [6][11], and part of the weight-loss evidence was conditional on gut enterotype rather than a main effect [3][5].
All 20 papers behind this claim with their DOIs and what each does to it, the panel’s arbitration, the evidence gap map and the open research questions. Free, and sent to your inbox.
We’ll also send you other claims from Dietary Fibre, one at a time, and tell you when a release or a pivotal trial changes a grade. Unsubscribe by replying.
One reviewer's only job is to attack the finding. The challenges below were weighed before the grade was set.
The claim treats 'higher fibre intake' as a single construct, but the corpus shows the effect is strongly fibre-type dependent: gel-forming alginate cut intake 22% while cellulose, guar and lower-dose products did not [13], and oat β-glucan produced no appetite or food-intake effect at all [17]. The generic claim overreaches relative to this specificity.
Several trials show satiety-hormone changes that do not translate into altered subjective satiety or intake: psyllium 'strongly modified' GI peptides yet postprandial appetite ratings were 'mostly similar' [6], and inulin failed to raise GLP-1/PYY [11]. Mechanistic signal is being read as behavioural effect.
Where it remains uncertain. The effect is not universal: oat beta-glucan had no appetite or intake effect [17], hormonal signals dissociated from subjective appetite [6], and some weight loss appeared only in specific gut-microbiota subgroups [3][5].
Aleatory
Weight changes are small (e.g. -0.87 kg [18], -2.8 kg [4]) relative to trial variability, so individual response varies around a modest mean.
Epistemic
Whether a given fibre acts is unresolved: gel-forming and fermentable fibres acted [13][16] while cellulose, guar at tested doses and oat beta-glucan did not [13][17].
Inferential
Appetite and intake effects were measured over 14-21 days or single postprandial periods [8][10][16][20], yet inferred toward sustained weight loss [10].
The load-bearing papers from a corpus of 20, each classified by what it does to the claim. Every DOI is taken from the corpus the claim was graded on.
RCT quantifying a modest weight loss of -2.8 kg from a specific fibre (resistant starch).
“RS supplementation for 8 weeks can help to achieve weight loss (mean -2.8 kg) and improve insulin resistance in individuals with excess body weight.”
Panel auditInternal validity: medium · scope of inference: Effect of resistant-starch supplementation on weight in adults with overweight or obesity over 8 weeks.Key limitations: small sample · no stated significance for weight change · much of paper is mouse mechanism
Direct randomised crossover support for the satiety limb with accompanying PYY/GLP-1 rise.
“There were significant delays in hunger and increased satiety for 1.5 to 2 hours after treatment with 10 g of Fibersol-2.”
Panel auditInternal validity: medium · scope of inference: Acute satiety response to 10 g soluble fibre with a meal in healthy adults.Key limitations: acute design · n=19 · effect only at 10 g dose · no weight outcome
RCT weight-loss support, though mechanism is dietary-fat binding rather than satiety.
“The mean body weight change from baseline was 3.8 ± 1.8 kg in IQ vs. 1.4 ± 2.6 kg in placebo (P < 0.001).”
Panel auditInternal validity: medium · scope of inference: Weight loss from an Opuntia-derived fibre complex in overweight/obese adults on a hypocaloric diet.Key limitations: fat-binding mechanism not satiety · diet counselling co-intervention · no satiety measure
The abstract reports dose-dependent hormone mRNA changes and body-fat correlations in rats, not a satiety-feeling or weight-loss result that establishes the claim.
Panel auditInternal validity: low · scope of inference: Dose-dependent gut-hormone and microbiota effects of inulin/oligofructose in lean and obese rats.Key limitations: animal model · mechanistic and correlational · no weight-loss contrast
4 of 20 papers shown. The full review lists all of them, with the panel’s arbitration →
Claims are graded at each quarterly release, and re-graded between releases only when a pivotal trial lands. Every change is a new version of the claim.
Converging primary RCT evidence supports a modest, directionally consistent effect, but fibre-type heterogeneity and a clear negative trial prevent a higher tier.
Release 2026-q4 re-graded every claim from its corpus under protocol v0.19. An earlier release's grade is shown for the record; it came from an earlier protocol and is not a movement.
Assumptions that carry weight but are not themselves established.
The panel records the gap that would most move the claim, and the study that would close it.
Satiety-to-weight causal chain. The corpus shows satiety effects and weight loss separately but not that the former drives the latter in the same people over time. The panel rates this the highest-importance open gap for the claim, and names the study design that would close it: A long-duration RCT measuring appetite/intake and body weight in the same cohort, testing whether early satiety response predicts later weight change.
Open question: Does an early increase in satiety or reduction in energy intake from a specific fibre predict sustained weight loss months later? Why it is still open: Appetite effects were measured only over days [8][10][16][20] and weight over weeks to months [4][9][18], never linked in the same participants.
Priors is a sceptical first reader, not peer review, and not medical advice.
Release 2026-q4 · graded 21 Oct 2026 · protocol v0.19